{
    "code": 0,
    "data": [
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submits the copy of public notice of financial results published on 4th February 2026 in Financial Express all India editions in English language and in Jansatta Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ed095ac-fe29-4971-b8de-4d90bc68d99b.pdf",
            "news_date": "2026-02-04 13:02:51"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "It is hereby informed the board of directors in its meeting held on 03.02.2026 considered and approved the appionment/ re-appiontment of the following :\r\n1. Mr. Harsh Pati Singhania as Additional  Director in the catergory of Non Executive Independent Director for a term of 5 years \r\n2. Mr. Salil singhal as Independent director for a second term of 5 years. \r\n3. Ms Vineeta Rai as Independent director for a second term of 5 years.\r\n4. Ms Madhumita Ganguli as Independent director for a second term of 5 years",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4cc27b9-33e3-4690-bdb2-f7b41a4c4d6e.pdf",
            "news_date": "2026-02-03 19:08:12"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Tuesday the 3rd February 2026 i.e. today considered and approved the following :-\r\n\r\n1. Considered and approved unaudited financial results of the Company for the quarter and nine months ended on 31st December 2025.\r\n2. Noted additional affidavit filed by Govt. of NCT of Delhi in the pending Free Patient Matter i.e. SLP (C) No. 29482/2009.\r\n3. Appointed Mr. Harsh Pati Singhania as an additional Director in the category of Non-executive Independent Director for a period of five years.\r\n4. Reappointed Mr. Salil Singhal as an Independent Director for second consecutive term of five years.\r\n5. Reappointed Ms. Vineeta  Rai as an Independent Director for second consecutive term of five years.\r\n6. Reappointed Ms. Madhumita Ganguli as Independent Director for second consecutive term of five years.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6a810c5-811a-4beb-b82e-ff30123dc0b1.pdf",
            "news_date": "2026-02-03 18:20:17"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31-12-2025.",
            "news_body": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve It is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 to consider and approve quarterly financial results for the quarter ended 31-12-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f0d2677-fca9-40fe-8bd7-7b5e26f2e1bf.pdf",
            "news_date": "2026-01-19 11:34:54"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed please find herewith a certificate dated 9/01/2026 issued by M/s MUFG Intime India Pvt Ltd registrar and share transfer agent of the company for the quarter ended 31/12/2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c6d4f95-3bdd-415d-a648-3bb8c3f53fa6.pdf",
            "news_date": "2026-01-14 16:51:37"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We wish to inform you that the trading window of the company will remain closed from 1st January 2026 till 48 hours after announcement / declaration of unaudited financial results for the quarter ending 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de08f114-c5f8-4a89-ba69-f4c740f38acf.pdf",
            "news_date": "2025-12-19 11:27:29"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "we wish to submit that the management of the company intends to participate in the \"annual flagship Conference- Anand Rathi G-200 Submit on 13th November 2025 at Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=305eebf5-3553-4204-8362-71eeeac7f0f9.pdf",
            "news_date": "2025-11-10 17:18:31"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copies of the public notice of the financial results published on 3rd November 2025 in the \"Financial Express\" all India editions in English language and in \"Jansatta\" Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7509568d-06b8-4a92-be3c-1673c9982b55.pdf",
            "news_date": "2025-11-03 15:28:39"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "The Board of Directors of the company has at its meeting held on Saturday 1st November 2025 i.e. today inter alia consider and approved the un-audited financial results for the quarter ended 30th September 2025 along with the limited review report of the statutory auditor. we are enclosing the same.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e9ea31-f300-4f4b-86a3-b5945b9b6172.pdf",
            "news_date": "2025-11-01 16:41:35"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve Un-Audited Financial Results For Quarter Ended 30Th September 2025.",
            "news_body": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2025 inter alia to consider and approve the meeting of board of directors of the company will be held on  1st November 2025 to consider and approve un-audited results for the quarter ended on 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e666bda-4bf1-4639-b819-98e7a721b656.pdf",
            "news_date": "2025-10-17 11:01:17"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find herewith a Certificate dated 3rd October 2025 issued by M/s. MUFG Intime India Pvt. Ltd. Registrar and Transfer Agent of the Company for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e02826e-aac5-48dd-9f96-48317cfd541b.pdf",
            "news_date": "2025-10-13 14:50:23"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "we wish to inform you that there is no information / announcement (including impending announcement) to be made by the company which in our opinion may have a bearing on the operation/performance of the company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=369191aa-7ece-41a2-87cd-3747098860a4.pdf",
            "news_date": "2025-10-09 16:50:52"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification Sought from Indraprastha Medical Corporation Ltd",
            "news_body": "The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on October 08 2025 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-10-08 18:53:21"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "we wish to inform you that there is no information/ announcement ( including impending announcement) to be made by the company which may have a bearing on the price / volume/ operation/ performance of the company which is required to be disclosed under regulation 30 of SEBI (LODR) Regulations  2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ec8cf72-0dcb-4515-8254-1871fef73558.pdf",
            "news_date": "2025-10-08 13:52:11"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Indraprastha Medical Corporation Ltd",
            "news_body": "The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on October 08 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-10-08 12:42:37"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "the 37th AGM of the Company was held on 24th September 2025 through Video Conferencing. In this regard please find the following:-\r\n1) Voting Results under Regulation 44 of the Listing Regulations; and \r\n2) Report of Scrutinizer dated 25th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bdf026f-e211-4ab6-9953-e6bdd9fabac2.pdf",
            "news_date": "2025-09-25 16:32:40"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We hereby submit per annexure summary of the proceedings of the 37th Annual general Meting of the Company held on 24th September 2025 through Video Conferencing and Other Audio-Visual Means.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9f9dcf1-b024-4037-96fa-c9295062a36d.pdf",
            "news_date": "2025-09-24 16:37:56"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "It is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons including Promoters Directors Key Managerial Personnel Designated Employees and their connected persons from Wednesday 1st October 2025 until 48 hours after the declaration of the unaudited financial results by the company for quarter ending 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c84cb7af-495b-4235-a42c-b2e47f1f8c4e.pdf",
            "news_date": "2025-09-24 16:27:00"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of newspaper advertisement for the opening of special window for re-lodgment of the transfer requests of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0ea8b3-ece3-463c-8299-9002bd29fc40.pdf",
            "news_date": "2025-09-16 16:57:55"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit the copies of the public notice for transfer of shares to IEPF published on 10th September 2025 in the financial express all India editions in English language and in Jansatta Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a60f97c8-54dc-4aa8-986e-9f44a21f1d99.pdf",
            "news_date": "2025-09-10 15:54:42"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of the public notice for completion of dispatch of Notice and Annual Report of the 37th AGM to be held on 24th Septembers 2025 Remote e-voting and Record date of dividend published on  4th September 2025 in In The financial express all India edition in English language and In Jansatta Delhi edition in Hindi Language",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5a2e73-2169-40bf-9feb-44965b966e53.pdf",
            "news_date": "2025-09-04 13:11:57"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "The Annual Report of the company for the financial year ended 31st March 2025 is hereby attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81eb01e3-728d-4644-863c-a68bbb66d96d.pdf",
            "news_date": "2025-09-01 15:08:48"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "AGM On 24Th September 2025",
            "news_body": "Pursuant to regulation 34(1)(a) of the Listing regulations the Annual report of the Company for the financial year ended 31st March 2025 along with Notice of the 37th AGM to be held on 24th September 2025 is attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2979eaf4-3995-431e-af0b-f47021ad4487.pdf",
            "news_date": "2025-09-01 14:59:13"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copies of the public notice of the 37th Annual General Meeting published in the \"Financial Express\"  all India editions in English language and in \"Jansatta\" Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=892804aa-0106-4b9a-b0a6-93a413d138f6.pdf",
            "news_date": "2025-09-01 10:50:44"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of the public notice of the Financial results published on 7th august 2025  In Financial express (all India edition) in English language and Jansatta Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2e5dc7e-c64b-43ba-a86a-b24292b5baf9.pdf",
            "news_date": "2025-08-07 14:16:29"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Annual General Meeting On 24Th September 2025",
            "news_body": "This is to inform you that the board of directors of the company at its meeting held on Wednesday 6th August 2025 (i.e. today) inter-alia considered and approved convening the 37th AGM of the company on Wednesday 24th September 2025 through video conferencing/OAVM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a49ae1c-0e49-4205-bdb0-b6ec43dbfe72.pdf",
            "news_date": "2025-08-06 18:26:16"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Corporate Action- Record Date For Dividend For The Year 2024-25",
            "news_body": "The board of directors of the company at its meeting held on Wednesday 6th august 2025 has fixed the record date as Thursday 18th September 2025 for the purpose of determining  the names of the shareholders who are entitled  for the dividend for the year 2024-25 and also for the purpose of AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04ec98ce-0a36-49a5-a2bf-d59f1a964deb.pdf",
            "news_date": "2025-08-06 18:17:11"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "This is to inform you that the Board of directors of the company as its meeting held on Wednesday 6th August 2025 (i.e. today) inter-alia considered and approved the following\r\n\r\n1. Appointed Mr Sudhir Jalan ( DIN 00111118) as an independent director subject to approval of the shareholder by way of special resolution at Ensuing AGM.\r\n2.Reappiontment of M/s Devarajan Swaminathan and Co. - Cost accounts as cost auditors of the company for the FY 2025-26.\r\n3. Approved the appointment of M/s RSM & co practicing company sectary as Sectorial Auditor for a period of % consecutive years commencing from from FY 2025-26  subject to approval of the shareholders at the ensuing AGM.\r\n\r\nThis is for your information and records.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7145074c-1574-4eea-bea9-f8f98966509c.pdf",
            "news_date": "2025-08-06 18:10:40"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "The board of directors of the company has at its meeting held on Wednesday 6th August 2025(i.e. today)  inter-alia considered and approved the items as follows:\r\n1. The un-audited financial results for the quarter ended on 30th June 2025\r\n2. Appointed Mr Sudhir Jalan  ( DIN 00111118) as an Independent director.\r\n3. approved convening AGM \r\n4. Fixed the record date.\r\n5. Appointment of cost auditor.\r\n6. Appointment of Sectorial auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66b9c632-9930-476d-9d16-9cf12970ba9a.pdf",
            "news_date": "2025-08-06 17:18:21"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting On 6Th August 2025",
            "news_body": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve this is to inform you that a meeting of board of directors  is scheduled to be held  on Wednesday  6th august 2025 inter- alia to consider and approve  of unaudited financial results for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b581b09-5d2e-4c0f-bc66-26ac371fc839.pdf",
            "news_date": "2025-07-22 17:08:47"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed please find herewith a certificate dated 10th July2025 issued by M/s MUFG Intime India private Limited Registrar & share Transfer Agent of the Company For the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=989de2d1-fa35-4050-a06d-688f2e0589c7.pdf",
            "news_date": "2025-07-12 11:25:38"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The trading window for dealing in shares of the company shall remain closed for all the designated persons including Promoters Directors Key Managerial Personnel Designated employees and their connected persons from Tuesday 1st July 2025 until 48 hours after the declaration of the unaudited financial results by the company for the quarter ending 30th  June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9037f3b3-4f3a-4993-85b9-cfe8da771b27.pdf",
            "news_date": "2025-06-20 11:23:39"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "We wish to inform you that the management of the Company intends to engage in discussion with Investors/ Analyst Meet on 24th June 2025 at 10 Am onwards in Mumbai:\r\n1. Motilal Oswal\r\n2. Nippon Mutual Funds\r\n3. Kotak Mutual Fund\r\n4. Kriss PMS \r\n\r\nFurther please note that no unpublished price sensitive information pertaining to the Company will be shared at the aforesaid Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a66a115-a062-46c4-8eab-7c9fdf980576.pdf",
            "news_date": "2025-06-17 15:58:22"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "we wish to inform you that Dr. Arum Rai ( DIN: 07159822) has completed  his second five year term as Independent director in the company on 25th May 2025. Therefore he ceases to be director and member of the Audit Committee & Nomination & Remuneration Committee of the board at end of the day on 25th may 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92098806-cafb-4b7e-93b6-b2d9a2653767.pdf",
            "news_date": "2025-05-26 12:56:33"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "we hereby inform you that Dr  Menaka Guruswamy ( DIN 08742679) has completed her tenure viz. first term of five (5) consecutive years on 22nd May 2025 as Independent Director on the Board of directors of the Company.\r\n\r\nshe has opted not to renew her second term as an independent Director hence she ceased to be a director of the company at the end of the day on 22nd May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d6fb3f2-a2eb-4e10-a31f-4784ce833293.pdf",
            "news_date": "2025-05-23 11:03:37"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "we hereby submit annual secretarial l compliance report for the year ended 31st march2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11b4bfb0-66f9-4868-8236-d51cf3037b61.pdf",
            "news_date": "2025-05-19 15:57:24"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of the public notice of financial results published on 17th May 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13ba329-7416-4cfb-95f5-f41bbd3f2b44.pdf",
            "news_date": "2025-05-17 15:59:48"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "This is to inform you that the Board of Directors of the company has at its meeting held on Friday 16th May 2025 (i.e. Today) inter-alia:\r\n\r\n1. Approved the Audited Financial Statements for the year ended 31st March2025 and Audited Financial Results for the quarter/year ended 31st March 2025 as recommended by the audit Committee; and\r\n2. Recommended a dividend @ 45% that is Rs 4.50 per share for the financial year 2024-2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23b750f2-20b8-4ff0-9d03-fa5dd29127da.pdf",
            "news_date": "2025-05-16 17:52:47"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting On 16Th May 2025",
            "news_body": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve This is to hereby inform you that meting of the Board of Directors of the Company will be held on Friday 16th May 2025 Inter Alia:-\r\n\r\n1. to consider and approve the audited financial results for the quarter/year ended 31st march 2025; and \r\n\r\n2. to consider and recommend dividend if any on equity shares of the Company for the financial year 2024-25.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=071e7ba6-fbb1-4f20-a7ac-86ea4a2da160.pdf",
            "news_date": "2025-05-05 11:27:08"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "we wish to inform that ICRA Limited has:\r\na) reaffirmed long-term - fund based - cash credit rating of {ICRA}AA (pronounced ICRA Double A) for Rs. 32.50 crore and short- term - non fund based rating of {ICRA}A1+ (pronounced ICRA A One Plus) for Rs. 30 crore bank facilities: and\r\nb) assigned long term- fund based - term loan credit rating of {ICRA}AA (pronounced ICRA Double A) for Rs. 100 crore to the company. \r\nThis is for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db003b18-e3f8-48d7-beae-ac94cece68e5.pdf",
            "news_date": "2025-04-28 12:53:00"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Indraprastha Medical Corporation Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232DL1988PLC030958</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYA RANJAN <br/>  Designation: AVP  CORPORATE AFFAIRS  LEGAL <br/> EmailId: priya_ranjan@apollohospitals.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: C P TYAGI <br/> Designation: CFO <br/> EmailId: tyagi@apollohospitals.com</div> </div> <div> <br/> Date: 28/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2dc93a7-2625-4e29-9d71-45503757af15.pdf",
            "news_date": "2025-04-28 12:45:13"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Enclosed please find herewith a certificate dated 02-04-2025 issued by RTA of the company for the quarter ended 31-03-2025.. this is for your information & record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba8aad2c-ad72-416f-9726-7f586a8db9ee.pdf",
            "news_date": "2025-04-09 13:31:45"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "it is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons including promoters directors key managerial personnel designated employees and their connected persons from Tuesday 1st April 2025 until 48 hours after declaration of audited Financial Results by the the Company for year ending 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5116356-5e70-4b72-89fa-0f715bec8d3d.pdf",
            "news_date": "2025-03-24 12:41:21"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of the public notice of the financial results published on 4th February 2025 in the Financial express all India Edition in English Language and in Jansatta Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7abd0070-5bb5-43a5-895e-c935b69348b4.pdf",
            "news_date": "2025-02-04 13:43:37"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "We are submitting herewith the Integrated Filing (Financial) for the quarter ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87eca675-2c9b-4512-a511-f62627ce2e92.pdf",
            "news_date": "2025-02-04 11:00:26"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "The board of Director of the company has as its meeting held on Monday 3rd February 2025 inter-alia considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December 2024 along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report.",
            "news_id": "ccf887ca-e33c-4cb6-9a72-2b8be9d7b550",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7b0ab43-7e52-4f81-bcea-dab4fa7dfe5e.pdf",
            "news_date": "2025-02-03 16:51:16",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "The board of Director of the company has as its meeting held on Monday 3rd February 2025 inter-alia considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December 2024 along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7b0ab43-7e52-4f81-bcea-dab4fa7dfe5e.pdf",
            "news_date": "2025-02-03 16:51:16"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copy of the public notice of loss of share certificates published on 1st February 2025 in the Financial express Delhi edition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f96d5d89-a787-4c98-813a-5f19845440e7.pdf",
            "news_date": "2025-02-01 16:20:08"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "THIS IS TO INFORM YOU THAT TH COMPANY HAS RECEIVE INTIMATION FROM THE BELOW MENTIONED SHAREHOLDER:\r\n\r\n1. SAHIL MIGLANI\r\nFOLIO NO- 651\r\nNO. OF SHARES-2000\r\nCERTIFICATE NO- 10517-10536\r\nDISTINCTIVE NO- 54310702-54312701",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dc0aabc-485e-4a39-889f-db8f97a74e4a.pdf",
            "news_date": "2025-01-31 15:23:24"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting To Consider And Approve Unaudited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Meeting of the Board of the Directors of the company will be held on Monday 3rd February 2025 to consider and approve the un-audited financial results for the quarter ended 31th December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8590950-90c0-458c-95a5-838a94e60090.pdf",
            "news_date": "2025-01-21 12:46:48"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copy of the public notice of loss of share certificates published on 14th January 2025 in the Financial Express - Delhi edition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaa05e0d-c9fa-492e-b51b-ca9dc3923d69.pdf",
            "news_date": "2025-01-14 13:06:29"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "enclosed please find herewith a certificate dated 4th Jan 2025 issued by M/s. MUFG Intime Private Limited Registrar & Share Transfer Agent of the Company for the quarter ended 31st Dec 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b85be890-28ef-4f4a-85a1-b89602d679c5.pdf",
            "news_date": "2025-01-09 15:33:41"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "this is to inform you that the company has received intimation from shareholder of loss of certificate as per details below\nName: Rajan Mayor Jt. Meenakshi Mayor folio No: 10813 No. of shares: 1500 certificate No-87962-87976 distinctive nos- 76949701-76951200",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baac596f-d443-41fd-8184-14ca7c05b770.pdf",
            "news_date": "2025-01-06 15:32:28"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copy of newspaper clipping relating to notice for  transfer of shares to IEPF published on 07-11-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdb214c6-7142-4946-9145-81e501a9e78a.pdf",
            "news_date": "2024-11-07 17:26:15"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "General Announcement",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=842c2f4b-0fb6-4764-8d58-e2b4a1d8568d.pdf",
            "news_date": "2024-11-01 13:13:56"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copy of the newspaper publication of financial result for the quarter ended 30th September 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec17b71b-6910-4c64-9985-38de8d4f57fb.pdf",
            "news_date": "2024-10-31 20:58:14"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "RESULTS FOR THE QUATERENDD 30TH SEPTEMBER,2024",
            "news_body": "THE BOARD OF DIRECTOR EETING HELD ON TODAY I.E., 30TH OCTOBER, 2024, HAS CONSIDERED AND APPROVED THE UN-AUDITED FINANCIAL RESULTS FOR HE QUATER ENDED 30TH  SEEPTEMBER, 2024.WE ARE  EN-CLOSING HEREWITH UNAUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT BY THE AUDITORS.",
            "news_id": "a3bbf484-7f71-4205-82c0-c5912aee2df4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=652eaa04-f83e-48b6-854a-8e7c8d70c8a5.pdf",
            "news_date": "2024-10-30 17:03:36",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "RESULTS FOR THE QUATERENDD 30TH SEPTEMBER,2024",
            "news_body": "THE BOARD OF DIRECTOR EETING HELD ON TODAY I.E., 30TH OCTOBER, 2024, HAS CONSIDERED AND APPROVED THE UN-AUDITED FINANCIAL RESULTS FOR HE QUATER ENDED 30TH  SEEPTEMBER, 2024.WE ARE  EN-CLOSING HEREWITH UNAUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT BY THE AUDITORS.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=652eaa04-f83e-48b6-854a-8e7c8d70c8a5.pdf",
            "news_date": "2024-10-30 17:03:36"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting On 30Th October, 2024",
            "news_body": "INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company will be held on Wednesday, 30th October, 2024, inter-alia, to consider and approve, the unaudited financial results for the quarter ended 30th September, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ed142c4-6867-44a9-bc02-3388906b8918.pdf",
            "news_date": "2024-10-21 10:55:40"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Enclosed please find copy of the certificate dated 15th October 2024 from the registrar of the company Link intime India Pvt Ltd for the quarter ended 30th September 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dc637fe-eafb-4753-9feb-6f57a5b3eab5.pdf",
            "news_date": "2024-10-15 21:18:39"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "the company received from shareholders as per details attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab577782-ccf9-4d58-bb50-ebb41edc474a.pdf",
            "news_date": "2024-09-27 16:34:38"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Trading window for dealing in shares of the Company will remain closed with effect from 1st October, 2024 till 48 hours after declaration of un-audited financial results for the quarter ending 30th September, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ebf937c-8554-4b8e-b455-6d55b9ab4447.pdf",
            "news_date": "2024-09-27 10:48:23"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "we hereby submit copy of scrutinizer Report and voting result, for the AGM held on 24th September, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff27599e-ea85-49cf-bfbb-5e9807b85169.pdf",
            "news_date": "2024-09-25 16:43:34"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Enclosed please find we hereby submit per annexure summary of the proceedings of the 36th annual general meeting of the company held on 24th September, 2024, through Video Conferencing and Other Audio- Visual Means.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e998e99-9c23-4964-ac6b-ebb8d7bad191.pdf",
            "news_date": "2024-09-24 13:53:07"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "please find the filed attached of newspaper publication published by the company today i.e., 19.09.2024 in Financial Express Delhi edition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4b1a897-f692-4e8e-9975-d1d75b3e5ed8.pdf",
            "news_date": "2024-09-19 17:10:14"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "THIS IS TO INFORM THAT COMPANY HAS RECEIVED INTIMATION FROM A SHAREHOLDER REGARDING LOSS OF SHARE CERTIFICATE & TO ISSUE DUPLICATE SHARE CERTIFICATE IN LIEU AS PER DETAILS ATTACHED",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d11d4c1-d0d2-4c35-9f84-b06176f09132.pdf",
            "news_date": "2024-09-16 16:31:58"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Book Closure For AGM And Declaration Of Dividend For The Year 2023-24",
            "news_body": "We hereby inform you that 36th AGM will be held on 24th September, 2024, through Video Conferencing and other Audio-Visual means. the register of members shall remain closed from 14th September, 2024 to 24th September, 2024, for the purpose of AGM and declaration of dividend for the year 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f86e3ea-7ebb-4464-9ea7-0664a9b9bb28.pdf",
            "news_date": "2024-09-02 16:37:48"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Enclosed please find Annual report for the year 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=406c362c-1eb4-45cd-9570-b6befb7e0c37.pdf",
            "news_date": "2024-09-02 16:31:06"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "36Th Annual General Meeting On 24Th September, 2024",
            "news_body": "We are enclosing herewith Annual report for the financial year 2023-24, including Notice of AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=200e4d5d-9e2b-4e74-9874-e980ee41beef.pdf",
            "news_date": "2024-08-31 12:51:03"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copies of public notice of the  36th AGM, published on 29th August, 2024 in the Financial Express all India edition in English language and in Janata, Delhi edition in Hindi.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a02f7aec-1e8d-44f3-be30-4bef57459b2a.pdf",
            "news_date": "2024-08-29 12:07:58"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "the company has issued duplicate share certificates as per details attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c0f8263-79d8-41d9-99d9-e5d4ea672ebe.pdf",
            "news_date": "2024-08-14 15:14:29"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "we hereby submit copies of the public notice of the financial results, published on 6th august,2024 in the Financial Express, all India edition in English language and in Jansatta, Delhi edition in Hindi Language .",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=264f71ae-dbe0-4da3-8df9-0e88e1a5850b.pdf",
            "news_date": "2024-08-06 14:52:31"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "the board of director of the company has, at its meeting held on 05-08-2024, inter-alia, considered and approved the following:1. the un-audited financial results for the quarter ended 30th June,2024.2. the re-appointment of Mr Shivakumar Pattabhiraman as Managing Director.3. Convening AGM4. Fixation of book Closure dates.this is for information please.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40d96142-3909-4ee7-b62e-c65687581c79.pdf",
            "news_date": "2024-08-05 18:08:53"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "we are enclosing herewith unaudited financial results for the quarter ended as approved by the board of directors at their meeting held today that is 05-08-2024. the board meeting ended at 5:45pm",
            "news_id": "97c97a37-e757-49e6-a0ee-57b2e525cdc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94f36614-a4b5-4fd3-bb6c-89709c56a21a.pdf",
            "news_date": "2024-08-05 18:00:10",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "we are enclosing herewith unaudited financial results for the quarter ended as approved by the board of directors at their meeting held today that is 05-08-2024. the board meeting ended at 5:45pm",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94f36614-a4b5-4fd3-bb6c-89709c56a21a.pdf",
            "news_date": "2024-08-05 18:00:10"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "the details of shareholders as follows:1. Name: Rohit R Khandelwal Jt. Rashmi Rohit Khandelwal, folio No-2508, No. of shares-100, Certificate No-27676, Distinctive Nos- 70187401-701875002. Rajesh Chandra Gupta, folio No- 10280, no of sharws-2600, Certificate No- 85904-85929, Distinctive Nos-76743901-76746500",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=600fd371-eed9-4450-adaf-e7ff8e416353.pdf",
            "news_date": "2024-08-03 17:10:19"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30Th June,2024.",
            "news_body": "INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 ,inter alia, to consider and approve A meeting of the Board of Directors of the company will be held on 05-08-2024, inter-alia, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2024b74a-9816-4320-8e99-7e2157b6881b.pdf",
            "news_date": "2024-07-24 11:08:29"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "This is with reference to certain news items circulating in the media pertaining to an alleged international kidney transplant racket involving a doctor and others. in this regard, please find enclosed copy of the Public Notice issued by the Company, the contents of which are self-explanatory.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=123fbcc3-7b83-4f6a-9995-935fd5e76cd5.pdf",
            "news_date": "2024-07-10 15:39:21"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "enclosed please find herewith a certificate dates 4th July,2024, issued by M/s Link Intime India Private Limited, Registrar & share Transfer Agent of the company, for the quarter ended 30th June,2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67ea4c76-ef57-4583-b0f5-5fe761ef6626.pdf",
            "news_date": "2024-07-08 15:29:28"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "This is to inform you that the Company has issued duplicate share certificates in respect of share certificates lost by the shareholders as per list attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=227ed73f-d41b-45d9-ae4d-3ed7b2414aca.pdf",
            "news_date": "2024-07-05 17:25:36"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "This is to inform you that the company has received following details from shareholder :1. Hitesh Khanna Jt. Anuj Khanna Folio No 17471, No. of shares 200, Certificate No -132121- 132122, Distinctive No- 81998701-819989002. Tarun Narula folio No6854, No of shares-200, Certificate Nos-44110-44111, Distinctive Nos 71830801- 71831000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79cd852f-eea0-4e41-a086-2a630e50d0cb.pdf",
            "news_date": "2024-07-01 17:32:46"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "This is to inform you that the Company has received intimation from following shareholders:1. Daniel Massy Folio No-9151, No. of shares -200, Certificate No- 82000 to 82001, Distinctive No- 76353501 to 763537002. Bharat Bhushan, folio No-3638, No. of share -200, Certificate No-32182 to 32183, Distinctive No-70638001 to 706382003. Vivek Kapoor, Folio No-11521, No of shares-500, Certificate Nos-91826 to 91830, Distinctive no''s- 77336101- 77336600",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=156af814-c56c-4a7b-a0f7-7770df56b59f.pdf",
            "news_date": "2024-06-29 15:27:10"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "It is to hereby informed that Trading Window for Trading window for dealing in shares of the company, will remain closed from effect of 1st Jusly,2024 till 48 hours after declaration of un-audited financial results for the quarter ending, 30th June, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66eb48d6-dd2d-4bd8-9e94-fcdaa4632f90.pdf",
            "news_date": "2024-06-26 15:41:00"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "This is to inform you that company has received information for loss of share certificate as follows:1. Smita S Joshi- Folio No. 20490, No. Of Shares-100, Certificate No-13747, Distinctive No- 68794501-687946002. Pushpa Devi- Folio No. 23030, No of shares-500, Certificate Nos- 159470 to 159471, 60539, 92223 to 92224, Distinctive Nos- 84733601 to 84733800, 74207401 to 74207500, 77375801 to 77376000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53773b4c-969a-46cf-bb17-06c32bc5b27a.pdf",
            "news_date": "2024-06-24 16:41:12"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submit copy of the public notice of loss of share certificates, published on 5th June,2024, in the Financial Express Delhi edition.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ebc78bd-df3a-4dd8-bda5-49a50bea8608.pdf",
            "news_date": "2024-06-05 15:20:15"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "this is to inform you that the company has received intimation from the following shareholder:1 Vinit Suri Jt. Neelam Suri Folio No- 642, No Of Shares-5000, Certificate No- 196162, Distinctive No- 54269702-54274701.2. Vinit Suri Jt.  Neelam Suri Folio No- 8338, No of Shares 3700,  Certificate Nos. 196163, Distinctive Nos. 75840801-75844500.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ff3a3e-0857-4c0b-99e2-d7ae0b69be64.pdf",
            "news_date": "2024-06-04 15:34:07"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "We hereby submit Annual secretarial compliance report from a practicing Company Secretary, for the year ended 31st March, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cd4f1a7-37a1-4096-b856-27a5fa3f69b7.pdf",
            "news_date": "2024-05-20 15:12:22"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We hereby submits the copies of the public notice of the financial results, published on 18th May, 2024, in the Financial Express, all India edition, in English language and in Jansatta, Delhi edition in Hindi language.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1112218e-94f0-4a36-96bf-5e2d6e3d0442.pdf",
            "news_date": "2024-05-18 15:26:22"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Approval Of Audited Financial Results & Recommendation Of Dividend For The Financial Year 2023-24",
            "news_body": "The Board of Directors of the Company at its meeting held on 17th May, 2024 i.e. today, interalia:1. Approved audited financial statements for the year ended 31st March, 2024; and2. Recommended a dividend @45% i.e. Rs. 4.50 per share for the financial year 2023-24.Details are given in the enclosed letter.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b98c318-b4e2-4f81-be3a-bd9e06065157.pdf",
            "news_date": "2024-05-17 14:23:58"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "news_id": "b911d872-201f-44c2-9019-0d8ac4fca05b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fc45c34-86f5-43a2-9f4d-c0954d7fac41.pdf",
            "news_date": "2024-05-17 14:16:02",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fc45c34-86f5-43a2-9f4d-c0954d7fac41.pdf",
            "news_date": "2024-05-17 14:16:02"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "news_id": "b3ec14ff-5a46-42a0-96f4-412f711d528b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53e300a-1e91-4e4a-8f33-896da11ddde0.pdf",
            "news_date": "2024-05-17 14:15:24",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia:1. approved the audited Financial Statements for the year ended 31st Marc,2024.2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24Details are given in the annexures.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53e300a-1e91-4e4a-8f33-896da11ddde0.pdf",
            "news_date": "2024-05-17 14:15:24"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Results For The Year Ended 31St March, 2024 And Dividend If Any For The Year 2023-2024",
            "news_body": "INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 17th May, 2024 inter alia-a) to consider and approve the audited financial results for the quarter/year ended 31st March, 2024,b) to consider and recommend dividend, if any, on equity shares of the Company for the Financial year 2023-24.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ae12daa-80b9-4750-8c5d-45d878d378cb.pdf",
            "news_date": "2024-05-09 16:05:38"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "AGM/EGM",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Further to our letter dated 22nd March, 2024, enclosing the Postal Ballot Notice dated 7th March, 2024, for seeking approval of the Members of the Company, for the below mentioned resolutions:1. Appointment of Mr. Sandip Somany (DIN 00053597) as an Independent Directors; and2. Appointment of Mr. Tejpreet Singh Chopra (DIN 00317683) as an Independent Director. the remote evoting concluded on 24th April, 2024 at 5 pm. Accordingly, enclosed please find Voting Results along with Scrutinizer''s Report dated 25th April, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b21541e-d5d4-43db-a795-6547fac0c5b8.pdf",
            "news_date": "2024-04-25 14:20:46"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "The Company has received intimation from shareholders on 22nd April, 2024, regarding loss of share certificates, as per details given below:1. Surinder Kumar Chachra Jt. Santosh Kumari, Folio No. 277, 1000 shares, Certificate Nos/ 2239 - 2248, Distinctive Numbers - 41403993 - 414049922. Chhaya Dinesh Shah, Folio No. 24898, 100 shares - Certificate Number - 23077, Dist. Number 69727501 - 697276001000 shares - Certificate Number 33262 - 33271, Dist. Numbers 70746001 - 70747000100 share - Certificate Number 41516, Dist. Numbers 71571401 - 71571500400 shares - certificate number 46867 - 46870, Distinctive number 77840201 - 77840600.100 shares - certificate number 128443, distinctive number 80997801 - 80887900200 shares - certificate numbers 128445 - 128446, distinctive number 80998001 - 80998200200 shares - certificate number 128452 - 128453, distinctive 80998701 - 80998900100 shares - certificate number 135017, distinctive number 82288301 - 82288400This is for your information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fad8c59-c7b7-4d1e-8dfa-d811a5ad92ec.pdf",
            "news_date": "2024-04-24 12:09:13"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Compliance Certificate For The Year Ended 31St March, 2024",
            "news_body": "Enclosed please find a copy of the certificate from a practicing Company Secretary Certifying that all certificates have been issued, for the financial year ended 31st march, 2024, within 30 days of the date of lodgment for transfer, sub-division, consolidation, etc.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5405dedb-6a88-4a6c-9fa6-94780a7a816d.pdf",
            "news_date": "2024-04-15 16:15:16"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "We wish to inform that ICRA Limited has reaffirmed:a) long-term credit rating of [ICRA]AA (pronounced  ICRA Double A) and short-term rating of [ICRA]A1+(pounced ICRA A one Plus) for Rs. 62.50 crore bank facilities;b) short-term credit rating of [ICRA]A1+ (pounced ICRA A one Plus) for Rs 40.00 Crore Commercial Paper to the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3243af55-d949-4d36-83a3-1205a81cb908.pdf",
            "news_date": "2024-04-09 15:02:04"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate For The Year Ended On 31St March,2024.",
            "news_body": "Enclosed please find the compliance certificate for the period 1st April, 2023 to 31st March, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=665b63f5-0cb4-49de-b6a4-5c8d7bd6509c.pdf",
            "news_date": "2024-04-08 15:34:50"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Enclosed please find herewith a Certificate dated 4th April, 2024, issued by M/s. Link Intime India Private Limited, Registrar & share Transfer Agent of the Company, for the quarter ended 31st March,2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e553cca2-4d9c-44c3-a4a3-b139ae3544da.pdf",
            "news_date": "2024-04-08 15:30:24"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Clarification On Movement In Share Price",
            "news_body": "We are of receipt of your email dated 5th April, 2024 seeking our clarification on increase in movement in price of shares of the Company across the exchanges. The detailed clarification enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=817f5d5a-19fc-4f15-aaf7-c577729a7e47.pdf",
            "news_date": "2024-04-06 11:19:41"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Bank Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E69E5292_8F40_48C1_B453_9006C8488480_111718.pdf",
            "news_date": "2024-04-06 11:17:21"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Indraprastha Medical Corporation Ltd",
            "news_body": "The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on April 5, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2024-04-06 07:55:11"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "This is to inform you that Mr. Vikram Bhat (DIN 09076418) has tendered his resignation (vide email dated 28th March, 2024) as Non- Executive Director (Nominee Director- Govt. of NCT of Delhi- Promoter of the Company) with effect from 28th March, 2024.The details as required under SEBI Circular is enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9360f58-61d9-4af5-a2d0-83fb57fec8c9.pdf",
            "news_date": "2024-04-01 12:29:15"
        },
        {
            "co_code": 12977,
            "bse_code": 532150,
            "isin": "INE681B01017",
            "ann_type": "Company Update",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "We hereby inform you that Mr. S Regunathan (DIN 00286505), Mr. Deepak Vaidya (DIN 00337276) and Mr. Satnam Arora (DIN 00010667) have completed their tenure viz. second term of 5 consecutive years on 31st March, 2024, as an Independent Director on the Board of Directors of the Company.The details as required under SEBI Circular are enclosed herewith.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9eaa8d90-146e-4b5f-8dcc-fcd102f77af7.pdf",
            "news_date": "2024-04-01 12:24:54"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2023.",
            "news_body": "The Board of Directors of the Company has at its meeting held on 6th February, 2024 inter-alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2023.",
            "news_id": "535e61a9-5e6a-4c1f-bdd8-a3e012e30bc0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53c34e2c-d05a-4c7f-83ee-5daa5ed40378.pdf",
            "news_date": "2024-02-06 17:51:03",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "we are enclosing hereby un-audited financial results for the quarter ended 30th June, 2023 along with a copy of the Limited Review Report by the Statutory Auditor of the Company.",
            "news_id": "a045d81c-b2e3-49dc-aa51-a619ed5a8c1f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fcd7af8-9762-4eae-bf5c-fda9414d90d9.pdf",
            "news_date": "2023-08-04 17:37:08",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th August, 2023",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th August, 2023 (i.e. today), inter-alia, considered and approved the following items: <BR> <BR> 1. The Un-audited Financial Results of the company for the quarter ended 30th June, 2023. <BR> 2. Change in Directorship - Resignation by Director<BR> 3. Convening Annual General Meeting  <BR> 4. Fixation of Record/Book Closure Dates<BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5:15 p.m.<BR>",
            "news_id": "de1f6c3a-e329-479d-979f-81f96c7369d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=878e1e75-8428-4890-a2c5-9a227cdadb36.pdf",
            "news_date": "2023-08-04 17:30:38",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended 31St March, 2023",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2023.",
            "news_id": "80edb1f1-c5c5-4222-b195-a2392dce8d4a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f44b06-1a53-4447-9e14-9d610a66cb5c.pdf",
            "news_date": "2023-05-23 17:27:09",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Financial Year Ended 31St March, 2023 And Recommendation Of Dividend",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Tuesday, 23rd May, 2023 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2023 and Audited Financial Results for the quarter/year ended 31st March, 2023, as recommended by the Audit Committee; and<BR> 2. Recommended a dividend @ 30% i.e. Rs. 3.00 per share for the financial year 2022-23. <BR>  The meeting of the Board of Directors commenced at 3.00 p.m. and concluded at 5:00 p.m.<BR> <BR> We shall inform you in due course of time, the date on which the Company will hold its Annual General Meeting for the year ended 31st March, 2023, and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders. <BR>",
            "news_id": "76140a29-d95f-49b2-9606-afa38c802931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eba612f-25d1-4fa9-8e85-f4b777177550.pdf",
            "news_date": "2023-05-23 17:18:16",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months  Ended 31St December, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.<BR> <BR>",
            "news_id": "3f66e89c-aa9a-46a4-963e-458f900717b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5923073-8127-48d5-85d9-bd51d299c1f5.pdf",
            "news_date": "2023-02-08 17:44:55",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th February, 2023",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter and nine months  ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.<BR>",
            "news_id": "05d70436-aa2e-4e44-ae57-f25f1bf8a38b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a395f11-2143-4c96-b605-0bff67afad1c.pdf",
            "news_date": "2023-02-08 17:40:39",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2022.",
            "news_id": "193b6ed7-c83a-43c9-bf85-c67d4dddd319",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46d1a0ac-2a0a-45c4-82a6-c65edd7d4139.pdf",
            "news_date": "2022-11-07 15:05:52",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th November, 2022 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year  ended 30th September, 2022, along with the Limited Review Report of the statutory auditor. <BR> <BR> We are enclosing herewith the Un-audited Financial Results for the quarter & half year  ended 30th September, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. <BR> <BR> The Board meeting commenced at 3.30 p.m. and ended at 5.25  p.m.<BR> <BR>",
            "news_id": "f8ca637d-76c4-4604-82ea-f37f34bd618e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2c1c749-a257-4dff-afe2-dd7b7b7e6dfb.pdf",
            "news_date": "2022-11-04 17:37:35",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 8th August, 2022 (i.e. today), inter-alia, considered and approved the following items:  <BR> 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2022, along with the Limited Review Report of the statutory auditor. <BR> 2. Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means.<BR> 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 17th September, 2022 to Friday, 23rd September, 2022  (both days inclusive) for the purpose of the AGM and declaration of dividend.<BR> The Board meeting commenced at 3.00 p.m. and ended at 5.20  p.m.<BR>",
            "news_id": "12ea6029-a2f5-4442-a095-6b43a0a1b2fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d089cf89-9ba0-40bd-bb4b-c201eaa3aaf9.pdf",
            "news_date": "2022-08-08 17:32:36",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2022.This is for your information and record.",
            "news_id": "94621010-4c1e-45c1-b19c-d015bf92b9f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4436a82-6767-41f9-b844-a28ad7f652f9.pdf",
            "news_date": "2022-05-24 14:50:11",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Audited Financial Results & Dividend",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; <BR> 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and <BR> 3. Re-appointed, based on the recommendation of the Audit Committee,  S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.  <BR>",
            "news_id": "826a173a-91fa-4834-a0b0-666aa9bf7102",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb82e258-fee8-4342-821d-2a008614bfe9.pdf",
            "news_date": "2022-05-20 18:15:40",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended 31St March, 2022",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 20th May, 2022 (i.e. today), inter-alia : <BR> <BR> 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; <BR> 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and <BR> 3. Re-appointed, based on the recommendation of the Audit Committee,  S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company.  <BR>",
            "news_id": "4b5976c9-9559-4f19-b56b-1b3ff58e8149",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=923fca41-73ee-4433-aac2-0607ad609c90.pdf",
            "news_date": "2022-05-20 18:12:09",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2021",
            "news_body": "The Board of Directors of the Company, at their meeting held on 8th February, 2022, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021.<BR> <BR> We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021, along with a copy of the Limited Review Report by the Auditors.<BR> <BR> The Board meeting started at 3.00 p.m. and ended at 5.55 p.m.",
            "news_id": "c7bb0cac-c846-4018-8946-5017c110c3d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eef341f-10cb-4dfb-9d0b-d426e37bc08d.pdf",
            "news_date": "2022-02-08 18:09:23",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2021",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2021.<BR> <BR> This is for your information and record.<BR>",
            "news_id": "3f13ef29-fa18-45fd-95ba-367b1be89673",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3308093b-da74-464b-9c7e-bae545d0f755.pdf",
            "news_date": "2021-11-16 11:53:50",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "The Board of Directors of the Company, at their meeting held on 9th November, 2021, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2021, along with a copy of the Limited Review Report by the Auditors.<BR> <BR> The Board meeting started at 3.00 p.m. and ended at 5.05 p.m.<BR>   <BR> This is for your information and record.<BR>",
            "news_id": "a8823cc3-c6d8-48e3-b34a-e6c1eabc8260",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84e1a554-5a4a-485a-bd81-c7d9036ed139.pdf",
            "news_date": "2021-11-09 17:14:27",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2021",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2021, along with the Limited Review Report of the statutory auditor.<BR> 2. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.<BR> 3. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means.<BR> 4. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021  (both days inclusive) for the purpose of the AGM.",
            "news_id": "88ba6c4e-54fc-45d0-ad8c-3ba84abb8371",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a52bde11-725e-4796-a46a-59f3d24d66f0.pdf",
            "news_date": "2021-08-09 17:44:43",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Trasnactions",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2021.",
            "news_id": "38f565a6-7e4a-4091-a4b8-e184695d1824",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4664f85d-2261-4245-a1bc-da2e212b141d.pdf",
            "news_date": "2021-06-19 10:43:12",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31-03-2021",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor.<BR> 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director'   from the Board of Directors of the Company.<BR> 3. Appointed Ms. Madhumita Ganguli (DIN :  00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to  8th June, 2026, subject to the approval of the shareholders of the Company.<BR> Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.<BR>",
            "news_id": "eed9f2e1-23f9-40ff-a735-ce7105e2c99d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06c49759-b6d8-494f-8b5e-6f9d04359d49.pdf",
            "news_date": "2021-06-09 18:07:29",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDRAMEDCO",
            "disp": "Indraprastha Medical Corporation",
            "bse_code": 532150,
            "isin": "INE681B01017",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting",
            "news_body": "This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: <BR> 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor.<BR> 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director'   from the Board of Directors of the Company.<BR> 3. Appointed Ms. Madhumita Ganguli (DIN :  00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to  8th June, 2026, subject to the approval of the shareholders of the Company.<BR> Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.<BR>",
            "news_id": "81a3a54f-3548-4415-b887-06de3d660558",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b87bda7-0b36-41bc-9e95-3ab1e2f193f8.pdf",
            "news_date": "2021-06-09 18:05:17",
            "seo": "indraprastha-medical-corporation-ltd",
            "ltp": 425.2,
            "ch": 23.349999999999966,
            "pch": 5.81062585541868,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4751,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}